E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/11/2011 in the Prospect News PIPE Daily.

Futura Medical plans £3.2 million private placement of ordinary stock

Nomura Code Securities assists in raising funds for working capital

By Devika Patel

Knoxville, Tenn., March 11 - Futura Medical plc said it will conduct a private placement of shares. Nomura Code Securities Ltd. is the agent for the £3.2 million deal.

The company will sell 4,737,402 ordinary shares at 67.5p each. The price per share is a 7.53% discount to the March 10 closing share price of 73p.

Proceeds will provide additional working capital, progress the company's earlier stage projects, RAD100 and TPR100-Rx, and bring new product opportunities developed in-house into the company's development pipeline.

Futura is a Guildford, England-based pharmaceutical and medical device company.

Issuer:Futura Medical plc
Issue:Ordinary shares
Amount:£3,197,746
Shares:4,737,402
Price:67.5p
Warrants:No
Agent:Nomura Code Securities Ltd.
Pricing date:March 11
Stock symbol:London: FUM
Stock price:69.5p at close March 11
Market capitalization:£49.26 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.